Literature DB >> 6248782

The measurement of angiotensin-converting enzyme in subjects receiving captopril.

J E Roulston, G A MacGregor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6248782     DOI： 10.1056/NEJM198008143030717

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  The influence of naloxone on the circulatory effects of captopril.

Authors:  P C Rubin; J A Millar; S Sturani; C Lawrie; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

2.  Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension.

Authors:  B C Campbell; A N Shepherd; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

3.  Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.

Authors:  D B Brunner; G Desponds; J Biollaz; I Keller; F Ferber; H Gavras; H R Brunner; J L Schelling
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

4.  Prolonged converting enzyme inhibition following captopril in patients with renal insuffficiency.

Authors:  B C Campbell; A N Shepherd; H L Elliott; K McLean; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

5.  Concentration effect modelling with converting enzyme inhibitors in man.

Authors:  A W Kelman; J L Reid; J A Millar
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

6.  Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.

Authors:  A B Atkinson; A M Cumming; J J Brown; R Fraser; B Leckie; A F Lever; J J Morton; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

7.  A potent converting enzyme inhibitor CGS 13928C. Drug profile in normal volunteers.

Authors:  M D Schaller; D B Brunner; J Nussberger; G A Turini; S B Sen; D Chen; B Waeber; H R Brunner
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients.

Authors:  C Richer; B Giroux; P F Plouin; B Maarek; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

9.  RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers.

Authors:  M Burnier; G A Turini; H R Brunner; M Porchet; D Kruithof; R A Vukovich; H Gavras
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

10.  Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.

Authors:  J Biollaz; J L Schelling; B Jacot Des Combes; D B Brunner; G Desponds; H R Brunner; E H Ulm; M Hichens; H J Gomez
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.